Adam — a young company with technology to 3D print bone grafts made out of ceramic bioglass and modified biopolymer — said today that it expects first human trials to start by the end of the year.
Officials at the Groton, Conn.– and Odessa, Ukraine–based company expect preclinical trials to finish this month. The Adam technology uses Kwambio printers and reduces the standard production cost of synthetic bones in half, from $0.12–$0.15/cm2 down to just $0.08.
Ideally, the bone graft dissolves as new bone grows, reducing the need for additional surgery, according to Adam.
“It’s definitely time to reshape our attitude towards bodies and find new solutions. We are confident that we are doing the right thing for all people, and that is the strongest motivation,” CEO Volodymyr Usov said in a news release.
Along with 3D printed bones, Adam is also developing Digital Body Atlases that people could theoretically have on hand with the information needed for precise bone replication. The company compares it to people having their own repair blueprints.
Adam has partnerships with the Advanced Regenerative Manufacturing Institute and Stanley Black & Decker, according to the company.
